NASDAQ:NXL

Nexalin Technology (NXL) Stock Forecast, Price & News

$0.47

+0.03 (+6.88%)

(As of 09/26/2023 ET)

Compare

Today's Range: $0.39
▼
$0.47
50-Day Range: $0.38
▼
$0.83
52-Week Range: $0.36
▼
$3.23

Volume: 3,278 shs
Average Volume: 38,520 shs
Market Capitalization: $3.46 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Nexalin Technology (NASDAQ:NXL) Stock

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.

NXL Price History

30 days | 90 days | 365 days | Advanced Chart

NXL Stock News Headlines

September 14, 2023 | barrons.com

Nexalin Technology Inc.

August 7, 2023 | finance.yahoo.com

Nexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related Symptoms

September 27, 2023 | Behind the Markets (Ad)

66,000% upside on tiny biotech?

The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.

August 3, 2023 | finance.yahoo.com

Nexalin’s CEO Mark White to be Interviewed Live on “The Big Biz Show” Today at 3PM Eastern Time

July 27, 2023 | finance.yahoo.com

Nexalin Technology Announces New Public Sector Division to Capitalize on Opportunities to Serve U.S. Government Agencies

July 10, 2023 | finance.yahoo.com

Nexalin Technology Announces Abstract Accepted for Presentation at 2023 Military Health System Research Symposium Validating the Potential of its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Mild Traumatic Brain Injury

June 1, 2023 | finance.yahoo.com

Nexalin Technology, Inc. and Wider Come Limited Announce Joint Venture Agreement to Advance Commercialization of Nexalin’s tACS Devices in the Asia Pacific Region

March 30, 2023 | finance.yahoo.com

Nexalin Technology Full Year 2022 Earnings: US$0.30 loss per share (vs US$1.43 loss in FY 2021)

September 27, 2023 | Altimetry (Ad)

Fraud Expert: Dump these three popular stocks

A major (and legal) market manipulation scheme is about to play out. It could cost you a fortune – or double your money. You choose. Find out what he knows, here.

March 27, 2023 | finanznachrichten.de

Nexalin Technology, Inc.: Nexalin Technology Provides 2022 Year-End Business Update

March 27, 2023 | finance.yahoo.com

Nexalin Technology Provides 2022 Year-End Business Update

January 18, 2023 | seekingalpha.com

NXL Nexalin Technology, Inc.

January 5, 2023 | finance.yahoo.com

Nexalin Technology CEO Provides Letter to Shareholders

November 14, 2022 | finance.yahoo.com

Nexalin Technology Announces Publication of a White Paper Validating its tACS Device for the Treatment of Generalized Anxiety Disorder

September 26, 2022 | investing.com

Nexalin Technology Inc (NXL)

See More Headlines

Receive NXL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nexalin Technology and its competitors with MarketBeat's FREE daily newsletter.

NXL Company Calendar

Today: 9/26/2023
Next Earnings (Estimated): 9/27/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Electromedical equipment
Sub-Industry: N/A
Sector: Business Services
Current Symbol: NASDAQ:NXL
CUSIP: N/A
CIK: 1527352
Web: www.nexalin.com
Phone: 832-260-0222
Fax: N/A
Employees: 6
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-1,700,000.00
Net Margins: -374.88%
Pretax Margin: -371.49%
Return on Equity: -47.37%
Return on Assets: -36.22%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.32
Quick Ratio: 4.19

Sales & Book Value

Annual Sales: $649,847.00
Price / Sales: 5.33
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.75 per share
Price / Book: 0.62

Miscellaneous

Outstanding Shares: 7,437,000
Free Float: N/A
Market Cap: $3.46 million
Optionable: Not Optionable
Beta: N/A

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Mark White (Age 61)
Pres, CEO & Director
Comp: $191.29k

Ms. Marilyn Elson (Age 69)
Chief Financial Officer
Comp: $356.73k

Dr. David Owens M.D. (Age 61)
Chief Medical Officer & Director

Mr. Michael Nketiah (Age 47)
Sr. VP of Quality, Clinical & Regulatory
Comp: $251.6k

Mr. John Patrick Claude
Co-Founder and Director of Engineering & Devel.

Mr. Joel Bradus
Director of Sales & Marketing

Key Competitors

View All Competitors

Insiders

Marilyn Elson
Bought 9,500 shares on 9/28/2022
Total: $10,640.00 ($1.12/share)

View All Insider Transactions

NXL Stock - Frequently Asked Questions

How have NXL shares performed in 2023?: Nexalin Technology's stock was trading at $0.7490 at the beginning of the year. Since then, NXL shares have decreased by 37.8% and is now trading at $0.4659.
View the best growth stocks for 2023 here.
Are investors shorting Nexalin Technology?: Nexalin Technology saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 11,100 shares, a decrease of 58.3% from the August 15th total of 26,600 shares. Based on an average trading volume of 27,300 shares, the short-interest ratio is presently 0.4 days. Approximately 0.2% of the company's shares are short sold.
View Nexalin Technology's Short Interest.
When is Nexalin Technology's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, September 27th 2023.
View our NXL earnings forecast.
When did Nexalin Technology IPO?: (NXL) raised $10 million in an IPO on Friday, September 16th 2022. The company issued 2,315,000 shares at $4.15 per share.

What is Nexalin Technology's stock symbol?: Nexalin Technology trades on the NASDAQ under the ticker symbol "NXL."
How do I buy shares of Nexalin Technology?: Shares of NXL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Nexalin Technology's stock price today?: One share of NXL stock can currently be purchased for approximately $0.47.
How much money does Nexalin Technology make?: Nexalin Technology (NASDAQ:NXL) has a market capitalization of $3.46 million and generates $649,847.00 in revenue each year.
How can I contact Nexalin Technology?: The official website for the company is www.nexalin.com. The company can be reached via phone at 832-260-0222 or via email at nxl@crescendo-ir.com.

This page (NASDAQ:NXL) was last updated on 9/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial